Related Experiment Video
Updated: Mar 27, 2026

A Guided Materials Screening Approach for Developing Quantitative Sol-gel Derived Protein Microarrays
Published on: August 26, 2013
Proteome Microarray-Guided Global View: Multiple Pharmacological Targets of Icariin
Guichun Gong1, Xianjin Tang1, Guanghun Yuan1
1Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education and Key Laboratory of Basic Pharmacology of Guizhou Province and Laboratory Animal Center, Zunyi Medical University, Zunyi, Guizhou, 563000, People's Republic of China.
Icariin (ICA) directly binds to 246 proteins involved in crucial cellular processes like protein folding and apoptosis. This study maps these interactions, offering a basis for understanding ICA
Area of Science:
- Pharmacology
- Biochemistry
- Molecular Biology
Background:
- Icariin (ICA) is a bioactive compound from Epimedium with diverse pharmacological effects.
- A comprehensive study on ICA's direct protein targets was previously lacking.
Purpose of the Study:
- To identify and map all proteins that directly bind to Icariin (ICA).
- To understand the cellular pathways influenced by ICA through its protein interactions.
Main Methods:
- Utilized the HuProt™ 20K human proteome microarray for high-throughput screening.
- Applied Protein-Protein Interaction (PPI) network analysis to cluster identified ICA-binding proteins.
Main Results:
- Identified 246 proteins that directly interact with Icariin (ICA).
- ICA-binding proteins are central to protein folding, ubiquitin-proteasome system, apoptosis, PI3K-Akt signaling, and nucleotide metabolism.
- These proteins formed 4 distinct functional clusters based on PPI network analysis.
Conclusions:
- An atlas of direct Icariin (ICA)-binding proteins was successfully constructed.
- Findings provide a theoretical foundation for ICA's therapeutic potential in diseases linked to dysregulated core cellular pathways.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
